NexgenRx (TSXV:NXG) 3-Year EBITDA Growth Rate : -27.90% (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is NexgenRx 3-Year EBITDA Growth Rate?

NexgenRx's EBITDA per Share for the three months ended in Dec. 2023 was C$0.00.

During the past 12 months, NexgenRx's average EBITDA Per Share Growth Rate was -31.80% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -27.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of NexgenRx was 55.50% per year. The lowest was -35.70% per year. And the median was 10.10% per year.

Competitive Comparison of NexgenRx's 3-Year EBITDA Growth Rate

For the Healthcare Plans subindustry, NexgenRx's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NexgenRx's 3-Year EBITDA Growth Rate Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, NexgenRx's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where NexgenRx's 3-Year EBITDA Growth Rate falls into.

NexgenRx 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

NexgenRx (TSXV:NXG) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

NexgenRx 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of NexgenRx's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

NexgenRx (TSXV:NXG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » NexgenRx Inc (TSXV:NXG) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

NEGXF:USA

Address

191 The West Mall, Suite 905, Toronto, ON, CAN, M9C 5L6

Website

http://www.nexgenrx.com

NexgenRx Inc administers, adjudicates and pays drug, dental and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers using proprietary computer software and provides ancillary services. Some of the products and services of the company are Dental Claims, Prescription Drug Claims and many more.